Logo image of ECOR

ELECTROCORE INC (ECOR) Stock Fundamental Analysis

NASDAQ:ECOR - Nasdaq - US28531P2020 - Common Stock - Currency: USD

5  +0.1 (+2.04%)

After market: 5 0 (0%)

Fundamental Rating

4

Taking everything into account, ECOR scores 4 out of 10 in our fundamental rating. ECOR was compared to 188 industry peers in the Health Care Equipment & Supplies industry. ECOR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ECOR is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ECOR had negative earnings in the past year.
In the past year ECOR has reported a negative cash flow from operations.
In the past 5 years ECOR always reported negative net income.
ECOR had a negative operating cash flow in each of the past 5 years.
ECOR Yearly Net Income VS EBIT VS OCF VS FCFECOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

ECOR's Return On Assets of -58.06% is on the low side compared to the rest of the industry. ECOR is outperformed by 70.21% of its industry peers.
Looking at the Return On Equity, with a value of -157.56%, ECOR is doing worse than 69.68% of the companies in the same industry.
Industry RankSector Rank
ROA -58.06%
ROE -157.56%
ROIC N/A
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
ECOR Yearly ROA, ROE, ROICECOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

ECOR has a Gross Margin of 84.97%. This is amongst the best in the industry. ECOR outperforms 96.28% of its industry peers.
ECOR's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ECOR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
ECOR Yearly Profit, Operating, Gross MarginsECOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

5

2. Health

2.1 Basic Checks

ECOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ECOR has been increased compared to 1 year ago.
The number of shares outstanding for ECOR has been increased compared to 5 years ago.
ECOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ECOR Yearly Shares OutstandingECOR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ECOR Yearly Total Debt VS Total AssetsECOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ECOR has an Altman-Z score of -10.73. This is a bad value and indicates that ECOR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -10.73, ECOR is doing worse than 80.32% of the companies in the same industry.
ECOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.73
ROIC/WACCN/A
WACC9.05%
ECOR Yearly LT Debt VS Equity VS FCFECOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

ECOR has a Current Ratio of 1.78. This is a normal value and indicates that ECOR is financially healthy and should not expect problems in meeting its short term obligations.
ECOR has a Current ratio of 1.78. This is in the lower half of the industry: ECOR underperforms 71.28% of its industry peers.
A Quick Ratio of 1.60 indicates that ECOR should not have too much problems paying its short term obligations.
ECOR has a Quick ratio (1.60) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.6
ECOR Yearly Current Assets VS Current LiabilitesECOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

ECOR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.07%, which is quite impressive.
The Revenue has grown by 57.09% in the past year. This is a very strong growth!
The Revenue has been growing by 60.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)45.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.62%
Revenue 1Y (TTM)57.09%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%23.44%

3.2 Future

ECOR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.24% yearly.
Based on estimates for the next years, ECOR will show a very strong growth in Revenue. The Revenue will grow by 21.84% on average per year.
EPS Next Y22.69%
EPS Next 2Y45.69%
EPS Next 3Y44.24%
EPS Next 5YN/A
Revenue Next Year24.6%
Revenue Next 2Y34.36%
Revenue Next 3Y36.97%
Revenue Next 5Y21.84%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ECOR Yearly Revenue VS EstimatesECOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M
ECOR Yearly EPS VS EstimatesECOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15 -20 -25

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ECOR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 25.31 indicates a quite expensive valuation of ECOR.
Based on the Price/Forward Earnings ratio, ECOR is valued a bit cheaper than 72.34% of the companies in the same industry.
ECOR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.15.
Industry RankSector Rank
PE N/A
Fwd PE 25.31
ECOR Price Earnings VS Forward Price EarningsECOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECOR Per share dataECOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ECOR's earnings are expected to grow with 44.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.69%
EPS Next 3Y44.24%

More info and screens

0

5. Dividend

5.1 Amount

ECOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELECTROCORE INC

NASDAQ:ECOR (5/30/2025, 8:00:01 PM)

After market: 5 0 (0%)

5

+0.1 (+2.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners18.95%
Inst Owner Change56.03%
Ins Owners18.26%
Ins Owner Change0.76%
Market Cap37.10M
Analysts83.64
Price Target25.7 (414%)
Short Float %5.14%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.23%
Min EPS beat(2)-27.74%
Max EPS beat(2)9.28%
EPS beat(4)3
Avg EPS beat(4)3.55%
Min EPS beat(4)-27.74%
Max EPS beat(4)17.87%
EPS beat(8)5
Avg EPS beat(8)-0.84%
EPS beat(12)5
Avg EPS beat(12)-4.22%
EPS beat(16)8
Avg EPS beat(16)1.82%
Revenue beat(2)0
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-2.02%
Max Revenue beat(2)-1.04%
Revenue beat(4)2
Avg Revenue beat(4)4.31%
Min Revenue beat(4)-2.02%
Max Revenue beat(4)11.95%
Revenue beat(8)4
Avg Revenue beat(8)3.45%
Revenue beat(12)7
Avg Revenue beat(12)2.42%
Revenue beat(16)8
Avg Revenue beat(16)1.38%
PT rev (1m)0%
PT rev (3m)2.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-97.6%
EPS NY rev (1m)2.92%
EPS NY rev (3m)-130.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.89%
Revenue NY rev (1m)-4.12%
Revenue NY rev (3m)-10.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.31
P/S 1.47
P/FCF N/A
P/OCF N/A
P/B 4.92
P/tB 4.92
EV/EBITDA N/A
EPS(TTM)-1.56
EYN/A
EPS(NY)0.2
Fwd EY3.95%
FCF(TTM)-0.94
FCFYN/A
OCF(TTM)-0.94
OCFYN/A
SpS3.39
BVpS1.02
TBVpS1.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -58.06%
ROE -157.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.97%
FCFM N/A
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
F-Score6
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.6
Altman-Z -10.73
F-Score6
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.62%
EPS Next Y22.69%
EPS Next 2Y45.69%
EPS Next 3Y44.24%
EPS Next 5YN/A
Revenue 1Y (TTM)57.09%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%23.44%
Revenue Next Year24.6%
Revenue Next 2Y34.36%
Revenue Next 3Y36.97%
Revenue Next 5Y21.84%
EBIT growth 1Y36.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.63%
OCF growth 3YN/A
OCF growth 5YN/A